Cargando…

Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice

Withaferin-A (WA) is the principle component of Withania somnifera (Ashwagandha). It has several biological activities including anti-cancer, anti-diabetic, neuroprotective, hepatoprotective and immune-modulatory properties. The acute and sub-acute toxicity of oral WA was investigated in mice. In th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Saurabh Kumar, Jadhav, Shraddha, Gohil, Dievya, Panigrahi, Girish Ch., Kaushal, Rajiv Kumar, Gandhi, Khushboo, Patil, Anand, Chavan, Preeti, Gota, Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742883/ https://www.ncbi.nlm.nih.gov/pubmed/36518386 http://dx.doi.org/10.1016/j.toxrep.2022.05.012

Ejemplares similares

Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial
por: Pires, Nichelle, et al.
Publicado: (2020)

ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients
por: Patil, Anand, et al.
Publicado: (2021)

Estimation of Withaferin-A by HPLC and standardization of the Ashwagandhadi lehyam formulation
por: Meena, Ajay Kumar, et al.
Publicado: (2021)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer
por: Gota, Vikram, et al.
Publicado: (2021)

Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs
por: Kulkarni, Preeti, et al.
Publicado: (2016)

A proteomic study to unveil lead toxicity-induced memory impairments invoked by synaptic dysregulation
por: Mohanraj, Nivedha, et al.
Publicado: (2022)

Withaferin A Associated Differential Regulation of Inflammatory Cytokines
por: Dubey, Seema, et al.
Publicado: (2018)

Evaluation of the geroprotective effects of withaferin A in Drosophila melanogaster
por: Koval, Liubov, et al.
Publicado: (2021)

Withaferin A Acts as a Novel Regulator of Liver X Receptor-α in HCC
por: Shiragannavar, Varsha D., et al.
Publicado: (2021)

Differential regional fatty acid distribution in normotensive and preeclampsia placenta
por: Rani, Alka, et al.
Publicado: (2015)

Modeling of COVID-19 with limited public health resources: a comparative study of three most affected countries
por: Srivastav, Akhil Kumar, et al.
Publicado: (2021)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020)

Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)

Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
por: Behl, Tapan, et al.
Publicado: (2020)

Withaferin A: From Ancient Remedy to Potential Drug Candidate
por: Sultana, Tahira, et al.
Publicado: (2021)

Evaluating anticancer properties of Withaferin A—a potent phytochemical
por: Atteeq, Maushma
Publicado: (2022)

Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage
por: Zhou, Zi-Xian, et al.
Publicado: (2022)

Withaferin A for COVID-19: a Network Pharmacology Approach
por: Mishra, Ashasmita S., et al.
Publicado: (2023)

In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways
por: Gupta, Snehil, et al.
Publicado: (2022)

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia
por: Nookala Krishnamurthy, Manjunath, et al.
Publicado: (2020)

Facial Necrotizing Fasciitis Disclosing Systemic Lupus Erythematosus
por: Kumar, Sunil, et al.
Publicado: (2013)

Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria
por: Kothekar, Amol T., et al.
Publicado: (2020)

COVID Ward in a Mental Health Establishment: Our Experience
por: Patil, Sunil Kumar Giriyappa, et al.
Publicado: (2021)

Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models
por: Dilli Batcha, Jaya Shree, et al.
Publicado: (2022)

Translation and Cross-Cultural Adaptation of Spinal Cord Independence Measure version III in Hindi Language
por: Kumar, Saurabh, et al.
Publicado: (2020)

Safety assessment of Withania somnifera extract standardized for Withaferin A: Acute and sub-acute toxicity study
por: Patel, Shruti B., et al.
Publicado: (2016)

The steroidal lactone withaferin A impedes T-cell motility by inhibiting the kinase ZAP70 and subsequent kinome signaling
por: Fazil, Mobashar Hussain Urf Turabe, et al.
Publicado: (2021)

Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior
por: Grin, Boris, et al.
Publicado: (2012)

Correction: Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2013)

Withaferin-A—A Natural Anticancer Agent with Pleitropic Mechanisms of Action
por: Lee, In-Chul, et al.
Publicado: (2016)

Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
por: Suman, Suman, et al.
Publicado: (2016)

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2017)

Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
por: Logie, Emilie, et al.
Publicado: (2020)

Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
por: Straughn, Alex R., et al.
Publicado: (2019)

Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
por: Straughn, Alex R., et al.
Publicado: (2021)

Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors
por: Bonandi, Elisa, et al.
Publicado: (2021)

Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3
por: Xia, Yangliu, et al.
Publicado: (2021)

Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH)
por: Ostwal, Vikas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdnv0dsc1534draghrod71qnlh